XK and COVID-19: substituted the NA gene coding region in the influenza genome with the membrane-anchored SARS-CoV-2 RBD region, creating a multicycle replicating influenza virus vector vaccine that is NA-deleted and targets both flu and COVID-19 (Loes et al., 2020).